Browse by specialty
Molecular Genetic Pathology (Medical Genetics)
In 2025, 5 Molecular Genetic Pathology (Medical Genetics) providers had general (non-research) payments reported to CMS. Half received less than $143 for the year, and nine in ten received less than $4,714.
5providers with payments in 2025
$143median total for the year
$4,714nine in ten received less than
$1,649average total for the year
Providers with the largest 2025 totals
Ordered by 2025 general-payment totals as reported to CMS. A large total is not evidence of wrongdoing; context is below the table.
| Provider | Location | 2025 general | All payments 2019-2025 including research |
|---|---|---|---|
| Mohammad O Hussaini | Saint Louis, MO | $7,686.08 | $77,061.32 |
| Harry Ostrer | Oklahoma City, OK | $255.91 | $255.91 |
| Annarita Nicosia | Baton Rouge, LA | $142.97 | $270.54 |
| Nikoletta Sidiropoulos | Burlington, VT | $118.29 | $51,282.75 |
| Julio C Delgado | Salt Lake City, UT | $42.60 | $61.37 |
| Jeffrey Milbrandt | Saint Louis, MO | $0.00 | $88,746.66 |
| Jennifer R Russell | Washington, DC | $0.00 | $105.39 |
| Benjamin W Darbro | Iowa City, IA | $0.00 | $200.00 |
| Oana E Vele | Stanford, CA | $0.00 | $21.39 |
| Roger D Klein | Beachwood, OH | $0.00 | $750.00 |
| Shahanawaz Jiwani | Frederick, MD | $0.00 | $339.34 |
| Rodrigo Tzovenos Starosta | Portland, OR | $0.00 | $620.92 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026).